Actinium Pharmaceuticals, Inc.
ATNM · AMEX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $53 | $60 | $65 | $73 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $1 | $1 | $0 | $0 |
| Total Curr. Assets | $54 | $61 | $66 | $75 |
| Property Plant & Equip (Net) | $1 | $2 | $2 | $2 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $0 | $0 | $0 |
| Total NC Assets | $2 | $2 | $2 | $2 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $56 | $63 | $69 | $77 |
| Liabilities | – | – | – | – |
| Payables | $0 | $8 | $7 | $8 |
| Short-Term Debt | $1 | $1 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $35 | $0 | $0 | $0 |
| Other Curr. Liab. | -$29 | $0 | $0 | $0 |
| Total Curr. Liab. | $7 | $8 | $7 | $8 |
| LT Debt | $1 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $35 | $35 | $35 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $35 | $0 | $0 | $0 |
| Total NC Liab. | $36 | $36 | $36 | $36 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $0 | $1 | $2 |
| Total Liabilities | $42 | $44 | $43 | $44 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$404 | -$399 | -$392 | -$376 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $418 | $0 | $0 | $0 |
| Total Equity | $14 | $19 | $26 | $33 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $56 | $63 | $69 | $77 |
| Net Debt | -$52 | -$59 | -$65 | -$73 |